Dalfampridine sustained-release for symptomatic improvement of walking speed in patients with multiple sclerosis

por Jeffery, Douglas R, Pharr, Emily Poole
Publicado 2010

Results from the 5-year, phase IV RENEW (Registry to Evaluate Novantrone Effects in Worsening Multiple Sclerosis) study

por Rivera, Victor M, Jeffery, Douglas R, Weinstock-Guttman, Bianca, Bock, Daena, Dangond, Fernando
Publicado 2013

Natalizumab versus fingolimod for patients with active relapsing-remitting multiple sclerosis: results from REVEAL, a prospective, randomised head-to-head study

por Butzkueven, Helmut, Licata, Stephanie, Jeffery, Douglas, Arnold, Douglas L, Filippi, Massimo, Geurts, Jeroen JG, Santra, Sourav, Campbell, Nolan, Ho, Pei-Ran
Publicado 2020

Incidence and course of depression in multiple sclerosis in the multinational BEYOND trial

por Schippling, Sven, O’Connor, Paul, Knappertz, Volker, Pohl, Christoph, Bogumil, Timon, Suarez, Gustavo, Cook, Stuart, Filippi, Massimo, Hartung, Hans-Peter, Comi, Giancarlo, Jeffery, Douglas R., Kappos, Ludwig, Goodin, Douglas S., Arnason, Barry
Publicado 2016

MS disease activity in RESTORE: A randomized 24-week natalizumab treatment interruption study

por Fox, Robert J., Cree, Bruce A.C., De Sèze, Jerome, Gold, Ralf, Hartung, Hans-Peter, Jeffery, Douglas, Kappos, Ludwig, Kaufman, Michael, Montalbán, Xavier, Weinstock-Guttman, Bianca, Anderson, Britt, Natarajan, Amy, Ticho, Barry, Duda, Petra
Publicado 2014

Predictors of disease activity in 857 patients with MS treated with interferon beta-1b

por Hartung, Hans-Peter, Kappos, Ludwig, Goodin, Douglas S., O’Connor, Paul, Filippi, Massimo, Arnason, Barry, Comi, Giancarlo, Cook, Stuart, Jeffery, Douglas, Petkau, John, White, Richard, Bogumil, Timon, Beckmann, Karola, Stemper, Brigitte, Suarez, Gustavo, Sandbrink, Rupert, Pohl, Christoph
Publicado 2015

Variability in detection and quantification of interferon β-1b–induced neutralizing antibodies

por Hartung, Hans-Peter, Kieseier, Bernd, Goodin, Douglas S, Arnason, Barry GW, Comi, Giancarlo, Cook, Stuart, Filippi, Massimo, Jeffery, Douglas R, Kappos, Ludwig, Bogumil, Timon, Stemper, Brigitte, Sandbrink, Rupert, Nakada, Yukiko, Nakajima, Haruhiko, Schwenke, Susanne, Lehr, Stephan, Heubach, Jürgen, Pohl, Christoph, Reischl, Joachim
Publicado 2012

Reversibility of the effects of natalizumab on peripheral immune cell dynamics in MS patients

por Plavina, Tatiana, Muralidharan, Kumar Kandadi, Kuesters, Geoffrey, Mikol, Daniel, Evans, Karleyton, Subramanyam, Meena, Nestorov, Ivan, Chen, Yi, Dong, Qunming, Ho, Pei-Ran, Amarante, Diogo, Adams, Alison, De Sèze, Jerome, Fox, Robert, Gold, Ralf, Jeffery, Douglas, Kappos, Ludwig, Montalban, Xavier, Weinstock-Guttman, Bianca, Hartung, Hans-Peter, Cree, Bruce A.C.
Publicado 2017